Home Boronic Acids 1312765-94-8
1312765-94-8,MFCD08752239
Catalog No.:AA000VR9

1312765-94-8 | (2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)boronic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$99.00   $69.00
- +
250mg
98%
in stock  
$169.00   $118.00
- +
1g
98%
in stock  
$442.00   $309.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000VR9
Chemical Name:
(2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)boronic acid
CAS Number:
1312765-94-8
Molecular Formula:
C14H20BNO4
Molecular Weight:
277.1239
MDL Number:
MFCD08752239
SMILES:
O=C(N1CCc2c(C1)ccc(c2)B(O)O)OC(C)(C)C
Properties

Downstream Synthesis Route
1339891-37-0    1312765-94-8   
C29H31N7O2 

[1]CurrentPatentAssignee:PFIZERINC-WO2011/130146,2011,A1Locationinpatent:Page/Pagecolumn121-122

1312765-94-8   
(S)-ethyl2-(5-bromo-4-(4,4-dimethylpiperidin-1-yl)-2,6-dimethylpyridin-3-yl)-2-(tert-butoxy)acetate 
 
tert-butyl(S)-6-(5-(1-(tert-butoxy)-2-ethoxy-2-oxoethyl)-4-(4,4-dimethylpiperidin-1-yl)-2,6-dimethylpyridin-3-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2017/25916,2017,A1Locationinpatent:Page/Pagecolumn39

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2017/25914,2017,A1Locationinpatent:Page/Pagecolumn37-38

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO;GLAXOSMITHKLINEPLC-WO2017/195112,2017,A1Locationinpatent:Page/Pagecolumn48

[4]CurrentPatentAssignee:GLAXOSMITHKLINEPLC;BRISTOL-MYERSSQUIBBCO-WO2017/195111,2017,A1Locationinpatent:Page/Pagecolumn44

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2017/25917,2017,A1Locationinpatent:Page/Pagecolumn52;53

[6]Parcella,Kyle;Wang,Tao;Eastman,Kyle;Zhang,Zhongxing;Yin,Zhiwei;Patel,Manoj;Tu,Yong;Zheng,BarbaraZhizhen;Walker,MichaelA.;Saulnier,MarkG.;Frennesson,David;Bowsher,Michael;Gillis,Eric;Peese,Kevin;Belema,Makonen;Cianci,Christopher;Dicker,IraB.;McAuliffe,Brian;Ding,Bo;Falk,Paul;Simmermacher,Jean;Parker,DawnD.;Sivaprakasam,Prasanna;Kish,Kevin;Lewis,Hal;Hanumegowda,Umesh;Jenkins,Susan;Kadow,JohnF.;Krystal,Mark;Meanwell,NicholasA.;Naidu,B.Narasimhulu[ACSMedicinalChemistryLetters,2022,vol.13,#6,p.972-980]

1312765-94-8   
(S)-isopropyl2-(5-bromo-4-(4,4-dimethylpiperidin-1-yl)-2,6-dimethylpyridin-3-yl)-2-(tert-butoxy)acetate 
 
tert-butyl(S)-6-(5-(1-(tert-butoxy)-2-isopropoxy-2-oxoethyl)-4-(4,4-dimethylpiperidin-1-yl)-2,6-dimethylpyridin-3-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2018/127801,2018,A1Locationinpatent:Page/Pagecolumn36

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2017/25916,2017,A1Locationinpatent:Page/Pagecolumn40-41

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2017/25914,2017,A1Locationinpatent:Page/Pagecolumn39

[4]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO;GLAXOSMITHKLINEPLC-WO2017/195112,2017,A1Locationinpatent:Page/Pagecolumn49-50

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC;BRISTOL-MYERSSQUIBBCO-WO2017/195111,2017,A1Locationinpatent:Page/Pagecolumn45;46

[6]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2017/25917,2017,A1Locationinpatent:Page/Pagecolumn54

[7]Parcella,Kyle;Wang,Tao;Eastman,Kyle;Zhang,Zhongxing;Yin,Zhiwei;Patel,Manoj;Tu,Yong;Zheng,BarbaraZhizhen;Walker,MichaelA.;Saulnier,MarkG.;Frennesson,David;Bowsher,Michael;Gillis,Eric;Peese,Kevin;Belema,Makonen;Cianci,Christopher;Dicker,IraB.;McAuliffe,Brian;Ding,Bo;Falk,Paul;Simmermacher,Jean;Parker,DawnD.;Sivaprakasam,Prasanna;Kish,Kevin;Lewis,Hal;Hanumegowda,Umesh;Jenkins,Susan;Kadow,JohnF.;Krystal,Mark;Meanwell,NicholasA.;Naidu,B.Narasimhulu[ACSMedicinalChemistryLetters,2022,vol.13,#6,p.972-980]

1312765-94-8   
ethyl(S)-2-(tert-butoxy)-2-(4-(4,4-dimethylpiperidin-1-yl)-2,6-dimethyl-5-(1,2,3,4-tetrahydroisoquinolin-6-yl)pyridin-3-yl)acetate 

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO;GLAXOSMITHKLINEPLC-WO2017/195112,2017,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC;BRISTOL-MYERSSQUIBBCO-WO2017/195111,2017,A1

[3]Parcella,Kyle;Wang,Tao;Eastman,Kyle;Zhang,Zhongxing;Yin,Zhiwei;Patel,Manoj;Tu,Yong;Zheng,BarbaraZhizhen;Walker,MichaelA.;Saulnier,MarkG.;Frennesson,David;Bowsher,Michael;Gillis,Eric;Peese,Kevin;Belema,Makonen;Cianci,Christopher;Dicker,IraB.;McAuliffe,Brian;Ding,Bo;Falk,Paul;Simmermacher,Jean;Parker,DawnD.;Sivaprakasam,Prasanna;Kish,Kevin;Lewis,Hal;Hanumegowda,Umesh;Jenkins,Susan;Kadow,JohnF.;Krystal,Mark;Meanwell,NicholasA.;Naidu,B.Narasimhulu[ACSMedicinalChemistryLetters,2022,vol.13,#6,p.972-980]

1312765-94-8   
(S)-2-(tert-butoxy)-2-(4-(4,4-dimethylpiperidin-1-yl)-2,6-dimethyl-5-(1,2,3,4-tetrahydroisoquinolin-6-yl)pyridin-3-yl)aceticacid 

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO;GLAXOSMITHKLINEPLC-WO2017/195112,2017,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC;BRISTOL-MYERSSQUIBBCO-WO2017/195111,2017,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Building Blocks
More >
Tags:1312765-94-8 Molecular Formula|1312765-94-8 MDL|1312765-94-8 SMILES|1312765-94-8 (2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)boronic acid